- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02428127
Efficacy of a Carbohydrate Drink on Speed, Agility and Power in School Going Children
August 29, 2018 updated by: GlaxoSmithKline
The purpose of this study is to investigate the impact of a beverage containing carbohydrate powder fortified with micronutrients on agility, speed, and power in school going children
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Pune, India, 411001
- GSK Investigational Site
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
12 years to 15 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Informed consent by participant's parents or legally accepted representative
- Good general health
- Non anemic children (Hb≥12 g/dl)
- Academy/development level athlete (at least 3 activity sessions per week, for a minimum of 2 hours of activity in each session e.g. hockey, football, team sports)
Exclusion Criteria:
- Child in care
- Allergy/Intolerance to study materials
- History of cardiovascular disorder, respiratory diseases, diabetes mellitus, serious infection/injuries/surgeries (within past 3 months)
- Participation in any nutritional study in past 1 year
- Substance abuse
- Children on any kind of medication in past 1 month of screening
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Test
20g Carbohydrate powder fortified with multiple micronutrients, reconstituted as a beverage in 200mL lukewarm water.
This will be administered twice a day
|
Carbohydrate beverage powder fortified with multiple micronutrients.
20g of study product will be administered orally twice a day
|
Active Comparator: Calorie matched protein powder
20g Calorie matched protein powder with 80% protein, reconstituted as a beverage in 200mL lukewarm water.
This will be administered twice a day
|
Calorie matched beverage powder with 80% protein.20g of study product will be administered orally twice a day
|
Placebo Comparator: Control
200mL lukewarm water given twice a day
|
lukewarm water
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in Agility fatigue index
Time Frame: Baseline and 4h post-baseline
|
Agility fatigue index (FI) will be calculated from Repeat Agility Performance Test, using 'Brower equipment'.
This assessment includes a 24 meter agility run, repeated on 6 occasions, with every sprint and recovery interval lasting for 65 seconds (eg.
if the first agility effort takes the participant 5 seconds, they will have 55 seconds to return to start line for a 5 seconds countdown before their second agility effort).
Agility FI=[100X(total agility time÷ideal agility time)]-100.
Here, ideal agility time is the best agility time for each participant multiplied by number of repetitions
|
Baseline and 4h post-baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in Speed fatigue index
Time Frame: Baseline and 4h post-baseline
|
Speed fatigue index (FI) will be calculated from Repeat Sprint Performance Test, using 'Brower equipment'.
This assessment includes a 30 meter sprint, repeated on 6 occasions, with every sprint and recovery interval lasting for 65 seconds (eg.
if the first sprint takes the participant 5 seconds, they will have 55 seconds to return to start line for a 5 second countdown before their second sprint).
Speed FI=[100X(total speed time÷ideal speed time)]-100.
Here, ideal speed time is the best speed time for each participant multiplied by number of repetitions
|
Baseline and 4h post-baseline
|
Change from baseline in Mean power output
Time Frame: Baseline and 4h post-baseline
|
Mean power output (MPO) will be calculated from Wingate Anaerobic Test, using 'Cycle ergometer'.
The participant is allowed to pedal at a constant pace, without resistance and then with additional weights (resistance).
This is repeated on three occasions.
Overall MPO=(sum of MPO from 3 repetitions at baseline)-(sum of MPO from 3 repetitions at post treatment).
|
Baseline and 4h post-baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- http://www.i-scholar.in/index.php/Ijnd/article/view/130266
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2015
Primary Completion (Actual)
May 1, 2015
Study Completion (Actual)
May 30, 2015
Study Registration Dates
First Submitted
April 23, 2015
First Submitted That Met QC Criteria
April 23, 2015
First Posted (Estimate)
April 28, 2015
Study Record Updates
Last Update Posted (Actual)
August 31, 2018
Last Update Submitted That Met QC Criteria
August 29, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- 203093
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Growth and Development
-
The University of Texas Health Science Center,...CompletedGrowth & DevelopmentUnited States
-
GlaxoSmithKlineCompletedGrowth and DevelopmentIndia
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineHammersmith Medicines ResearchCompletedGrowth and DevelopmentUnited Kingdom
-
DSM Nutritional Products, Inc.Charite University, Berlin, Germany; Ludwig-Maximilians - University of Munich and other collaboratorsCompletedGrowth and DevelopmentSerbia
-
GlaxoSmithKlineMahajan Imaging CenterCompleted
-
GlaxoSmithKlineWithdrawn
-
Mead Johnson NutritionCompletedGrowth | Cognitive DevelopmentUnited States
-
Annamalai UniversityJohns Hopkins Bloomberg School of Public Health; Global Alliance for Improved... and other collaboratorsUnknownChild Development | Morbidity | Cognitive Development | Physical GrowthBangladesh
-
Société des Produits Nestlé (SPN)Veeva Systems; SAS InstituteNot yet recruitingBrain | Growth & DevelopmentChina
Clinical Trials on Carbohydrate beverage powder
-
Old Dominion UniversityRecruitingAnomalies GastrointestinalUnited States
-
Old Dominion UniversityCompletedImpaired ThermoregulationUnited States
-
GlaxoSmithKlineCompleted
-
Kangbuk Samsung HospitalCompleted
-
University of FloridaHeermann Anesthesia FoundationCompleted
-
NestléNational University Hospital, Singapore; National University, SingaporeCompleted
-
University of Texas at AustinDairy Research InstituteCompletedOral Glucose Tolerance Test | High Fat Tolerance TestUnited States
-
Appalachian State UniversityDole Food CompanyCompleted
-
Yonsei UniversityUnknown
-
USDA Beltsville Human Nutrition Research CenterUnited States Army Research Institute of Environmental MedicineCompletedHealthy VolunteersUnited States